1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Chagas Cardiomyopathy Global Clinical Trials Review, H2, 2014

Chagas Cardiomyopathy Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Chagas Cardiomyopathy Global Clinical Trials Review, H2, 2014" provides data on the Chagas Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chagas Cardiomyopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chagas Cardiomyopathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Chagas Cardiomyopathy Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Chagas Cardiomyopathy 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Central and South America 11
Clinical Trials by G7 Countries: Proportion of Chagas Cardiomyopathy to Cardiovascular Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Chagas Cardiomyopathy to Cardiovascular Clinical Trials 15
Clinical Trials in E7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Chagas Cardiomyopathy 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Drugs 24
Clinical Trial Overview of Top Institutes / Government 25
Universidade Federal de Minas Gerais 25
Clinical Trial Overview of Universidade Federal de Minas Gerais 25
Evandro Chagas Institute of Clinical Research 26
Clinical Trial Overview of Evandro Chagas Institute of Clinical Research 26
Ministerio da Saude, Brazil 27
Clinical Trial Overview of Ministerio da Saude, Brazil 27
Fundacion Cardiovascular de Colombia 28
Clinical Trial Overview of Fundacion Cardiovascular de Colombia 28
University Hospital Gottingen 29
Clinical Trial Overview of University Hospital Gottingen 29
Instituto do Coracao 30
Clinical Trial Overview of Instituto do Coracao 30
University of California, Los Angeles 31
Clinical Trial Overview of University of California, Los Angeles 31
The Hospital for Sick Children 32
Clinical Trial Overview of The Hospital for Sick Children 32
Johns Hopkins University 33
Clinical Trial Overview of Johns Hopkins University 33
National Heart, Lung, and Blood Institute 34
Clinical Trial Overview of National Heart, Lung, and Blood Institute 34
Five Key Clinical Profiles 35
Appendix 58
Abbreviations 58
Definitions 58
Research Methodology 59
Secondary Research 59
About GlobalData 60
Contact Us 60
Disclaimer 60
Source 60

List of Tables
Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials by Region, 2014* 6
Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Chagas Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 9
Chagas Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries, 2014* 10
Chagas Cardiomyopathy Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 11
Proportion of Chagas Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 12
Chagas Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Chagas Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Chagas Cardiomyopathy to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 15
Chagas Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 16
Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Chagas Cardiomyopathy Therapeutics, Global, Terminated Clinical Trials, 2014* 21
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Universidade Federal de Minas Gerais, 2014* 25
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Evandro Chagas Institute of Clinical Research, 2014* 26
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministerio da Saude, Brazil, 2014* 27
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacion Cardiovascular de Colombia, 2014* 28
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Gottingen, 2014* 29
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto do Coracao, 2014* 30
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014* 31
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2014* 32
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014* 33
Chagas Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 34

List of Figures
Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Chagas Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 9
Chagas Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 10
Chagas Cardiomyopathy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 11
Proportion of Chagas Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 12
Chagas Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Chagas Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Chagas Cardiomyopathy to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 15
Chagas Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 16
Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Chagas Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Chagas Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Chagas Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
GlobalData Methodology 59

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.